Verdence Capital Advisors LLC Adma Biologics, Inc. Transaction History

Verdence Capital Advisors LLC

  • $1.23 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 31, 2024
BUY
$3.08 - $4.52 $1,133 - $1,663
368 Added 3.53%
10,786 $48,000
Q3 2023

Oct 25, 2023
SELL
$3.47 - $4.61 $3,105 - $4,125
-895 Reduced 7.91%
10,418 $37,000
Q2 2023

Jul 28, 2023
BUY
$3.12 - $4.22 $2,446 - $3,308
784 Added 7.45%
11,313 $41,000
Q1 2023

Apr 24, 2023
SELL
$3.01 - $3.87 $4,271 - $5,491
-1,419 Reduced 11.88%
10,529 $34,000
Q4 2022

Jan 20, 2023
BUY
$2.47 - $3.88 $29,511 - $46,358
11,948 New
11,948 $0

Others Institutions Holding ADMA

# of Institutions
317
Shares Held
189M
Call Options Held
917K
Put Options Held
91.6K
View Full List

About ADMA BIOLOGICS, INC.

ADMA Quotes by TradingView
  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.23B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Verdence Capital Advisors LLC Portfolio

Follow Verdence Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verdence Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verdence Capital Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email